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o f  HS by deposits o f  Ig. In vitro studies revealed 
that autoantibodies complexed to nucleosonwl
antigens can inhibit the binding o f  the anti-HS 
monoclonal antibody to HS. Whether this also oc­
curs in vivo remains to be determined. (Am J
Pathol 1995, 146:753-763)
Autoimmune Diseases,' (.'entrai laboratory o f the Dutch Red
Cross Hlood Transfusion Sert Ice, 1066 CX Amsterdam, The 
Netherlands
Recently we found in biopsies o f  human lupus ne­
phritis a nearly complete loss o f  heparan sulfate 
(HS) staining in the glomerular basement mem­
brane ( GBM). To clarify the relationship between 
HS staining and albuminuria in lupus nephritis, 
we studied MRL/lpr mice with short (<7 days) or  
prolonged duration o f  albuminuria (14-21 days) 
and compared these with mice o f  different ages
without
stained fo r  mouse inumi
sections were
(Ig), HSf
heparan sulfate proteoglycan (HSPG)-core p ro ­
tein 
with
laminiti in immunofluorescence. In mice
>ed albuminuria HS staining in the
capilia ty  loops had almost completely 
'ed, whereas staining was unaltered in
non-albuminurie mice (P = 0.001). In mice with
short duration o f albuminuria, there was a len-
V toward a decrease o f  HS staining (P
»
0.06). The expression o f HSPG-core protein and 
other extra cellular matrix (IÌCM) components 
was unaltered in all groups. HS staining corre­
lated inversely with albuminuria ( r H = -0.55; P < 
0.001) and with staining o flg  deposits in the cap-
ry loops (  r s -0.74; P < 0.001). Despite the
Systemic lupus erythematosus (SLE) Is an autoim­
mune disease characterized by the occurrence of a 
multitude of autoantibodies, primarily directed 
against nuclear antigens.1 Glomerulonephritis, char­
acterized by albuminuria and deterioration of renal 
function, is one of the most serious manifestations of 
this disease.2 The MRL/I (MRLJpr/lpr) mouse strain is 
a generally accepted animal model for SLE,3 As In 
human SLE, numerous autoantibodies occur and 
most animals develop albuminuria and progressive 
loss of kidney function between 3 and 6 months of age 
with a 50% mortality rate at 6 months. Histologically, 
a diffuse proliferative glomerulonephritis is observed, 
and Immunofluorescence studies reveal variable 
amounts of deposits of Immunoglobulins (Ig) and 
complement factors in the mesangium and along the 
glomerular capillary walls.3'*1 
Deposition of heparan sulfate (HS) reactive autoan­
tibod ies has been proposed as an early event in the
development of lupus nephritis.'’ 7 HS is the nega-
glycosamlnoglycan chain of
heparan sulfate proteoglycan (HSPG). It Is an Intrinsic 
constituent of the glomerular basement membrane 
(GBM) and responsible for the majority of the anionic 
sites in the GBM.M m These anionic sites are held re­
sponsible for the charge dependent permeability of 
the GBM,l1,ia although the relative contribution of
nearly complete loss ofHS staining in the GBM in 
mice with prolonged albuminuria, there was no 
change in glomerular HS content as assessed by 
agarose elee 
We conclude that the development o f  albuminuria 
in MRL/lp r mice is accompanied by a loss o f  HS 
staining in the GBM, probably due to the masking
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other negative charged molecules within the glomer­
ular capillary wall, like the sialoprotein podocalyxln, is 
still a matter of debate. Consequently, loss of these
Recently, we13-17anionic sites leads to albuminuria, 
found that staining of HS in the GBM with the anti-HS 
monoclonal antibody (MAb) JM-403 had completely 
disappeared in 12 of 13 renal biopsies of human lu­
pus nephritis, whereas staining of the HSPG-core pro­
tein was unaltered.18
in a metabolic cage with free access to water. Mice 
assigned to groups 1,2,3, and 4 were sacrificed after 
collection of the urine. After the kidneys were per­
fused with saline before removal, a part was imme­
diately snap frozen in liquid N2 for immunofluores­
cence and a small piece was immersed in Bouin's 
solution for light microscopy. From animals assigned 
to group 5 another urine sample was collected after 
14 days, just before the kidneys were taken for im-
To clarify the relationship between albuminuria and 
HS staining in SLE, we studied MRL/I mice with dif­
ferent stages of renal disease and compared these 
with mice without albuminuria of different ages. In
munofluorescence and light microscopy. Urinary al­
bumin content was measured by a radial immunod­
iffusion technique as described.33 Physiological 
albuminuria was determined by measuring albumin-
these groups of mice, we studied by immunofluores­
cence the relation of deposited Ig with the staining of 
HS, HSPG-core protein and laminin in the glomeruli. 
We measured the glomerular HS content in the glo-
uria in 50 BALB/c mice. The upper level was defined 
as the mean albuminuria pîus twice the standard de­
viation.
In a separate experiment animals were divided into
meruli of these mice to elucidate whether a potential 5 groups in exactly the same way as described above
decreased staining of HS was due to decreased HS (n = 24 per group). The kidneys of these animals were
content of the GBM or to blocking of the staining by 
deposited immune complexes. Since we have found
flushed with iron oxide (Fe30 4) for the isolation of glo­
meruli24 (see below).
that autoantibodies complexed to nucleosomal anti­
gens can bind to HS in vitro'9'20 and to GBM-HS in
vivo,2' * 2 we examined in ELISA whether the binding 
of the anti-HS MAb to HS could be inhibited by these 
complexes.
Histology
For light microscopy tissue fragments fixed in Bouin's
solution were dehydrated and embedded in para-
Materials and Methods
plast (Amstelstad B.V., Amsterdam, The Nether­
lands). Four-micron sections were stained with peri-
Animals
MRL/I ( M R L, Ipr/lpr) mice were bred in the animal fa-
odic acid—Schiff and silver methenamine/’3
Immunofluorescence was performed on 2-\j cryo­
stat sections of all kidneys to study deposition of
cilities of the University of Nijmegen from stock origi- mouse Ig and staining of ECM components. Depo-
nally obtained via the Scripps Clinic and Research sition of mouse Ig was studied in direct immunofluo-
Foundation (La Jolla, CA) from the Jackson Labora- rescence by incubating the sections with FITC-
tory (Bar Harbor, ME). Five groups of mice were se- labeled F(ab)r. sheep anti-mouse lg (Cappel
ected based on age and magnitude of albuminuria Organon Technika NV, Turnhout, Belgium) 10 mg/ml
which was screened every week with Albustix (Boeh- 
ringer Mannheim, Mannheim, Germany). Group 1
diluted 1:750 in PBS containing 1% (w/v) BSA.
The presence of HS was examined by incubating
consisted of 12-week-old mice {n = 8) without albu­
minuria (Albustix < 300 pg/ml). Group 2 consisted of
the sections with a biotinylated (1 mg/ml)"' mouse 
anti-rat HS MAb that only recognizes HS in basement
36-week-old mice (n = 8) without albuminuria (Al­
bustix < 300 pg/ml). Group 3 consisted of 18- to 24- 
week-old mice (n = 8) without albuminuria (Albustix
<300 Mg/ml). Group 4 consisted of 18- to 24-week-old 
mice (n = 8) with short duration of albuminuria (Al­
bustix > 1000 pg/ml, albuminuria period <7 days). 
Group 5 consisted of 18-to 24-week-old mice (n = 8) 
which had a positive result on screening (Albustix > 
1000 pg/ml) on three subsequent occasions (albu­
minuria period at least 14 days, but not more than 21 
days).
After assigning a mouse to one of the five study 
groups, urine was collected the next day for 18 hours
membranes (JM-403,;’li). The sections were 
treated with an avidin-biotin blocking kit (Vector Labo­
ratories Inc., Burlingame, CA) before they were incu­
bated with the biotinylated JM-403 MAb in a dilution 
of 1:60. FITC-labeled streptavidin (Extravidin, Sigma, 
St. Louis, MO) 1.5 mg/ml diluted 1:400 was used to 
develop the sections. The sections were stained in 
indirect immunofluorescence with a goat anti-human 
HSPG-core antiserum prepared in our laboratory, 
diluted 1:200. FITC-labeled rabbit arrti-goat lg (de 
Beer Med BV, Hilvarenbeek, The Netherlands), 16 
mg/ml diluted 1:500 was used as a secondary anti­
body. The sections were also stained with a rabbit
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anti-EHS laminili antiserum (diluted 1:400, prepared 
in our laboratory) followed by FITC-labeled mouse 
anti-rabbit Ig, which was affinity purified and preab­
sorbed for human, mouse, goat and sheep Ig (Jack­
son Laboratories Inc., West Grove, PA) 1 mg/ml di­
luted 1:40, as secondary antibody. The anti-rat and 
anti-human ECM antibodies used in these studies all 
cross-reacted with mouse constituents in immuno­
fluorescence,
After the staining procedure, the sections were em­
bedded In aquamount (BDH Ltd. Poole, UK) and ex­
amined with a Zeiss fluorescence microscope. 
Blinded sections were examined by three indepen­
dent investigators. The intensity of the staining in the 
capillary loops and the mesangium was scored semi- 
quantitatively on a 0 to 4+ scale in at least 30 glo­
meruli per mouse kidney. The 0 to 4 scale was defined 
as follows. For staining of ECM components in cap­
illary loops, no staining at all was scored 0, staining 
of 25% of all capillary loops and/or 75% decrease of 
staining intensity (as compared with a normal BALB/c 
glomerulus) was scored 1 ; staining of 50% of all cap­
illary loops and/or 50% decrease of staining intensity 
was scored 2; staining of 75% of all capillary loops 
and/or 25% decrease of staining intensity was scored 
3, and normal staining of all capillary loops was 
scored 4. For staining of ECM in the mesangium, not 
the intensity but the amount of mesangial staining was 
scored, since staining intensity of ECM components 
in the mesangium in all animals was equal. No stain­
ing at all was scored 0; mild staining was scored 1 ; 
moderate staining was scored 2; strong staining was 
scored 3; and severe staining was scored 4. For stain­
ing of IgG in capillary loops and mesangium, both the 
amount and intensity of staining were scored. No 
staining at all was scored 0; mild staining was scored 
1; moderate staining was scored 2; strong staining 
was scored 3; and severe staining was scored 4.
Elution Studies
Attempts to elute I g from sections were made. To this 
end sections were incubated with pepsin (Sigma) 10 
Mg/ml in 0.1 mol/L acetate pH 4.528; 0.12 mol/L 
glycine-NaOH, pH 1229; 0.12 mol/L glycine-HCI, pH 
2.8?9; 0.1 mol/L Tris (hydroxymethyl) aminomethane, 
pH 11.5; heparin (Organon, Oss, The Netherlands) 5 
mg/ml in PBS30 and 2 mol/L NaCI for 1 hour at 37 C3a 
and 0.1 mol/L glycine, 6 mol/L urea pH 3.5 for 1 hour 
at 4 C.31 Next the sections were stained for mouse Ig 
or for HS as described above. When this procedure 
failed to remove Ig from the section, the procedure 
was repeated overnight at 37 C. To study the effect of
these different elution procedures on HS, also kidney 
sections of young 12-week-old non-albuminuric 
MRL/I mice and 8- week-old BALB/c mice were 
treated similarly.
Measurement of HS in Glomeruli
The Isolation of glomeruli was performed as de­
scribed before.34 Ali steps were carried out in the 
presence of protease inhibitors (1 mmol/L phenylm- 
ethylsulfonylfluoride, 0,05% NaN3, 20 mmol/L EDTA, 
and 100 Kl units Trasylol). The obtained material con­
sisted of more than 95% glomeruli. The number of 
glomeruli isolated were assessed by counting in trip­
licate in a hemocytometer. Next, the glomeruli were 
spun down and treated with 1 mg papain (from pa­
paya latex, Sigma) in 1 ml 0.05 mol/L Na-acetate, 2 
mol/L NaCI, 10 mmol/L cystelne-HCI (pH 5.7) over­
night at 55 C to isolate the glycosaminoglycans 
(GAGs). Protein was precipitated using trichloroace­
tic acid in a final concentration of 5% (w/v), and after 
centrifugation 10% (v/v) 3 mol/L Na-acetate solution 
was added. GAGs were precipitated by adding cold 
ethanol (-80 Cfor 30 minutes), spun down, and dried. 
The isolated GAGs were tested by agarose electro­
phoresis on a 1% (w/v) agarose gel with 50 mmol/L 
Ba-acetate, pH 5.0, as electrophoresis buffer.32 A 
mixture of HS (20 ng/ml), dermatan sulfate (10 ng/ml), 
and chondroitin sulfate (10 ng/ml) was used as 
marker. The GAGs on the gel were stained with 
AgNOa.
Furthermore, HS isolated from glomeruli was meas­
ured in an inhibition ELISA (submitted for publication). 
In brief, Nunc-immuno plates (Maxisorp F96, GIBCO 
BRL, Paisley, UK) were coated with HS (Seikagagu 
Kogyo Ltd., Tokyo, Japan) 50 pg/ml in PBS overnight 
at room temperature. Plates were blocked with PBS 
containing 1% (w/v) gelatin, 150 pl/well for 2 hours at 
37 C. A constant amount of MAb JM-403, giving 50% 
of the maximal ELISA signal, was added to a serially 
diluted sample of the glomerular digest in PBS/1 % 
gelatin and incubated for 1 hour at 37 C. Thereafter, 
this mixture was added to the HS-coated plates (100 
pi/well) and incubated for 1 hour at 37 C. After wash­
ing the plates, a peroxidase-labeled goat anti-mouse 
IgM antiserum (Southern, Birmingham, AL) was 
added, diluted 1:1000 in PBS containing 0.05% 
Tween 20,100 pl/well. The plates were washed again 
and 3,5,3',5'-tetramethylbenzidine (Merck, Darm­
stadt, Germany) 100 |jg/ml in 0.11 mol/L sodium ac­
etate (pH 5.5) containing 0.003% Hi;0p was added, 
100 pl/well. The color development was stopped by 
adding 100 pi 2 mol/L HaSO„ per well after 15 minutes
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and the OD at 450 nm was measured in a Titertek 
multiscan. Inhibition was calculated according to the 
following formula: [1 -  (A450 + inhibitor/A450 -  in­
hibitor)] x  100%. Then, the 50% inhibition point was 
assessed and compared with a standard curve.
Inhibition of Binding of the Anti-HS MAb 
JM-403 to HS in ELISA by Nucleosomes 
and Immune Complexes
Whether nucleosomes or immune complexes con­
taining nucleosomal antigens were able to inhibit the 
binding of the anti-HS MAb to HS was evaluated in 
ELISA. After coating and blocking Nunc plates as de­
scribed above, plates were incubated for 1 hour at 
room temperature with a serial dilution of nucleo­
somes, purified non-complexed anti-nucleosome 
MAbs and anti-nucleosome MAbs complexed to nu­
cleosomal particles as described.22 After washing 
the plates, a constant amount of MAb JM-403 giving 
50% of the maximal absorption signal was added for 
1 hour at room temperature. Next, plates were de­
veloped as described above. To control for nonspe­
cific inhibition, the same preparations were tested for 
their ability to inhibit an anti-HSPG core MAb (Chemi- 
con Internationa! Inc, Veenendaal, The Netherlands) 
to HSPG. EHS-HSPG (Collaborative Biomedical Prod­
ucts, Bedford, MA) was coated 50 pg/ml, 100 pl/well 
in 0.05 mol/L carbonate buffer pH 9.6 to Nunc plates 
overnight at room temperature, and the ELISA was 
further carried out as described for the anti-HS ELISA.
Statistical Analysis
Statistical analysis was performed using the Mann- 
Whitney ¿7 test. P< 0.05 (two sided) was considered 
to be statistically significant. Spearman's correlation 
coefficient was used in linear regression analyses.
Results
Albuminuria and Renal Histology
The selection of animals for the different groups was 
based on a screening by Albustix. This screening 
proved to be a good selection procedure for the al­
bumin excretion during 18 hours. Non-albuminuric 
mice in groups 1 (12 weeks old), 2 (36 weeks old), and 
3 (18-24 weeks old) did show a somewhat variable 
urinary albumin excretion that did not, however, ex­
ceed the upper level of the normal physiological al­
buminuria in mice (120 pg/18 hours) (Table 1). Mice
Age Albuminuria
Group (Median in Weeks) (Median in pg/18 Hours)
1 12 15 (3-56)*
2 36 53(27-120)
3 21 (18-24)t 52 (20-100)
4 23 (18-24) 1,700(1,200-21,400)
5 19 (18-24) 3,400 (1,000-18,200)
4,800 (2,100-23,800)*
‘Range of albuminuria in parentheses.
' Age range in parentheses.
^Second measurement of albuminuria, which took place 2 
weeks after the first.
of group 4 (short duration of albuminuria) and group 
5 (albuminuria for 2 to 3 weeks) did show a marked 
albuminuria that increased over time in group 5 ani­
mals.
Glomerular deposition of mouse Ig in all mice that 
did not show albuminuria (groups 1, 2, and 3) was 
predominantly located in the mesangial areas and in­
creased with age. In addition to increased mesangial 
Ig deposits, mice with albuminuria showed also a sig­
nificant increase in Ig deposition along the glomerular 
capillary loops, which was most pronounced in mice 
with prolonged albuminuria (Figures 1 and 2).
Expansion of mesangial matrix, as assessed by 
light microscopy, was seen in all groups of mice when 
compared with young (12-week-old) mice. This ex­
pansion was most marked in mice with prolonged al­
buminuria, although it was also seen in mice with re­
cent onset of albuminuria and, to a lesser extent, in 
age-matched non-albuminuric mice. Together with 
this mesangial expansion we found an increase in 
mesangial staining for the ECM components HSPG- 
core protein (Figure 4) and laminin (not shown). The 
anti-HS MAb JM-403 did not reveal HS in the mesan­
gium but only recognized HS in the GBM. When stain­
ing for ECM components was scored in the capillary 
loops, it was found that HSPG-core protein and lami­
nin (Figures 3 and 4) were equally detected in all 
groups. In contrast, HS staining was markedly de­
creased in the capillary loops of glomeruli of mice with 
prolonged albuminuria (group 5), compared with 
young 12-week-old mice (group 1) and non- 
albuminuric age-matched controls (group 3). In mice 
with short duration of albuminuria (group 4) there was 
a tendency toward a decrease in HS staining that, 
however, did not reach statistical significance (P = 
0.06) (Figures 3 and 4).
There was an inverse correlation between HS stain­
ing and albuminuria (rs = -0.55, P < 0.001) (Figure 
5) and between HS staining and deposits of Ig 
located along the capillary loops {rs = -0.74, P <
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Figure 1. Deposition o f Ig in glomerular ccipillciiy loops and mesangium in glomeruli of mice hi the five groups scored semiquant itatirely in im- 
munojluorescence on a 0 to 4 H- scale. Deposition o f Ig is ohsenvd in all groups, Ig deposits in glomerular capillary loops irere only significantly 
increased in albuminuric mice ( groups 4 and  5). Older mice t groups J -  5 ) show an increase o f mesangial Ig deposits when compared uith ytmng 
1 J*week-old mice. Bars represent medians with intercjaartile ranges. M droit]) h 12 weeks, no albuminuria. □  Group J: Jù weeks, tut albumin- 
uria. □  Group J: ltt-24 weeks, no albuminuria. ^  Group 4: IS-24 treeks, recent albuminuria. 1 I Group 5.* IK-24 weeks, prolonged albuminuria. 
* = P < 0.0S rersus i^roup 1, § = P < 0.05 tarsus group 2, c|f — P< 0.0S rersus ^roup 3.
0.0001 ) (Figure 6). Ig deposits in glomerular capillary
loops and albuminuria were also correlated (rs -  
0.67, P< 0.001).
Elution Studies
Because the above-mentioned data suggested that 
HS was masked by Ig, we tried to elute Ig from the 
sections to restore the HS staining in the GBM. After 
elution using heparin or 2 mol/L NaCI, there was no 
effect or only a slight effect on I g depositions. After 
elution using glycine—HCI, pH 2.8, Ig depositions 
were partly removed. However, on a normal mouse 
kidney section, HS was partly degraded, leading to 
reduction of HS staining. All other elution procedures 
mentioned in Materials and Methods led to complete 
removal of Ig deposits. However, they induced a total 
loss of HS staining on normal kidney sections. Taken 
together, no elution procedure led to total removal of 
Ig, while leaving HS intact.
Measurement of Glomerular HS Content
Glomeruli were isolated and pooled for each group. 
From an equal amount of glomeruli the GAGs were 
extracted and analyzed on agarose gel electrophore­
sis. Despite the almost complete disappearance of 
HS staining in mice with prolonged albuminuria, we 
found comparable amounts of HS and, although to 
lesser extent, equal amounts of dermatan and chon- 
droitin sulfate in glomeruli of mice from all groups (Fig­
ure 7). When HS from the GBM was measured more 
quantitatively In an Inhibition ELISA using the antl-HS 
MAb JM-403, the HS content did also not markedly 
differ In any of the groups examined (Table 2).
In Vitro ELISA Studies
To elucidate in more detail potential mechanisms for
the decrease in HS staining In the GBM, we analyzed 
whether nucleosomes, pure non-complexed mono-
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deposition o f Ig in glomeruli o f non-albuminuric age-matched 
and mice with prolonged albuminuria ( group 5, C). While mice
11 increase o f deposition of Ig in the glom erular capillary 
in the group o f mice with prolonged albuminuria (A X
clonal anti-nuclear antibodies or monoclonal anti- 
nuclear antibodies complexed to nucleosomal par­
ticles (described in ref. 22) could inhibit the binding 
of JM-403 to HS in ELISA. As shown in Figure 8, im­
mune complexes and nucleosomes were able to in­
hibit dose-dependently this binding, whereas the 
pure, non-complexed monoclonal anti-nuclear anti­
body did not inhibit. In contrast nucleosomes or im­
mune complexes were not able to inhibit the binding 
of an anti-HSPG MAb to HSPG.
Discussion
Alterations of GBM-HS have been observed in various 
glomerular diseases with albuminuria18 such as dia­
betic nephropathy,33“37 membranous glomerulone­
phritis,38 and SLE.18,39 In SLE it has been suggested 
that the binding to the GBM of HS-reactive antibodies 
or immune complexes initiates renal disease,5"~7-20 
and it has been found that anti-HS reactivity is asso­
ciated with renal disease in human SLE.40 42 Re­
cently, we reported that in the majority of biopsies of 
patients with lupus nephritis, HS staining in the glo­
merular capillary loops was completely negative, 
whereas staining for the HSPG-core protein was still 
intact.18 On the other hand, the relationship between 
albuminuria and HS staining is not unequivocal, since 
in patients with IgA nephropathy and Alport’s syn­
drome and a marked albuminuria, we found a normal 
staining for GBM-HS.18
We studied the relationship between HS staining 
and albuminuria in lupus-prone MRL/I mice with dif­
ferent stages of renal disease. When we examined 
deposition of Ig in these groups of mice we observed 
that a significant increase of mesangial Ig deposition 
in mice with increasing age, compared with young
mice 12 weeks of age, was not related to increased 
glomerular permeability for proteins. When the Ig de­
posits were located in glomerular capillary loops a 
correlation was found with albuminuria. These find­
ings suggest that deposition of Ig in the glomerular 
capillary loops is causally related to the development 
of albuminuria. Linear regression analysis revealed a 
strong correlation between these two parameters.
Both the extent of Ig deposits in the capillary loops 
and the albuminuria were correlated with a decreased 
staining of GBM-HS, while the staining for HSPG-core 
protein and laminin was not altered in all groups stud­
ied. This means that in mice with prolonged albumin­
uria, the expression or the accessibility of the HS side 
chain is diminished, while this is unaltered for its car­
rier protein (HSPG-core protein). These findings are in 
line with a recent report in which administration of 
polyclonal rabbit anti-HSPG antibodies (reactive with 
the core protein, but not with the side chain) in NZB/W 
mice did not competitively inhibit the binding of au­
toantibodies to HS in the GBM.43 The negative cor­
relation between GBM-HS and albuminuria in our 
study suggests that the neutralization of HS related 
anionic sites is related to albuminuria in lupus nephri­
tis. The negative correlation between GBM-HS stain­
ing and capillary loop Ig deposition suggests that the 
blocking of the negative charge in the GBM was 
caused by the deposition of immune complexes in the 
capillary loops. Although a correlation does not prove 
a cause and effect, this hypothesis is in line with an 
earlier report which stated that treatment of lupus 
mice with corticosteroids decreased the localization 
of immunoreactants in the GBM.44 This treatment pre­
served the presence of anionic sites within the GBM, 
linking, as we found, the status of anionic sites to the 
magnitude of GBM deposition. The assumption that
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Figure 3. Stain hig o f IIS,  HSPG-core protein, and laminili in the capillary loops o f glomeruli o f mice in the different groups scored sem ¡quel nt na­
tively in immunofluorescence on a 0 to 4+  scale. Staining oj'HS is markedly decreased In mice with prolonged albuminuria, {group 5) and there 
is a tendency toward a decrease in mice with recent albuminuria ( group 4), whereas staining o f HSPG-core protein and lu mi ni n is unaltered in 
all groups. Bars represent medians with interquartile ranges. ■  Group I: 12 weeks, no albuminuria. LI Group 2: Jit weeks, no albuminuria. □  
Group A: 1H-24 weeks, no albuminuria, ¡H Group 4: IS-24 weeks, recent albuminuria. [3 Group 5: / 2 4  weeks, prolonged albuminuria. J*< 
0.0S versus group 1. § = P < 0.05 versus g roup  2. 'f  — P < 0.05 versus group 3. #  ^  P< 0.05 versus group 4.
HS associated anionic sites are covered by immu- 
noreactants was confirmed by the finding that the 
glomerular content of HS was unchanged in all ex­
perimental groups as assessed by agarose electro­
phoresis and quantitative HS inhibition ELISA. Experi­
ments which attempted to elute the I g and uncover HS 
failed because no elution procedure was capable of 
eluting all deposited Ig while leaving HS intact. Re­
moval of Ig is only possible by procedures which also 
destroy HS. However, we were able to “uncover" HS 
in vitro, since papain digestion of isolated glomeruli 
lead to HS which could be shown in the inhibition 
ELISA and in agarose electrophoresis.
These experiments indicate that HS is still present 
in the GBM but that its accessibility for the anti-HS
sition, has been described in lupus nephritis. In 
NZB/W mice it was shown that a decrease in anionic 
sites preceded the deposition of immune complexes 
in the glomerular capillary wall.46 In another study in 
NZB/W mice, it has been shown that deposition of 
immune complexes in the GBM is associated with 
loss and/or redistribution of fixed anionic sites in 
areas of increased permeability to anionic protein. 
We also studied albuminuric and non-albuminuric 
NZB/W and GVH mice and found also in these strains 
disappearance of HS staining in albuminuric mice 
(data not shown), showing that this phenomenon oc­
curs also in these models of lupus nephritis. Theo­
retically, two mechanisms could explain the relation­
ship between decrease of HS associated anionic
3!)
MAb is masked by immune complexes occurring dur- sites and albuminuria. First, the decrease itself could
ing this disease. For lupus nephritis, a decrease of the be instrumental in the development of albuminuria,
net negative charge of the GBM due to the binding of Arguments in favor of this explanation are that binding
cationic proteins or immune complexes has been of cationic molecules19,14 or of the anti-HS MAb JM- 
suggested before. In this respect, deposition of neu­
trophil45 or platelet-derived cationic proteins30 has 
been mentioned. Also the disappearance of anionic
4034/ to HS can induce albuminuria. Also our obser­
vation that reduction of HS staining was correlated to 
albuminuria in nonimmunological glomerular dis- 
sites, as a consequence of immune complex depo- eases like diabetic nephropathy48 and adriamycin
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Figure 4. Represo ¡tat ire examples o f the im- 
muno/lttorescence f i rulings o f staining o f 
fJSPG'-core fwolein in non-albuminuric age- 
matched control mice (group A), mice with 
short dn rat it it i o f  albuminuria (. group 4, C ). 
a n d  mice teith prolonged albuminuria ( group 
\  E ) and  staining ofH S in these groups { group 
/í. B; group  /, D; and  group 5. F). Note the 
slight increase o f  USPCncore protein in the ex­
panded mescingium, most abundantly in mice 
teith ftrolouged tdbumiuuria {group 5, E). 4*i 
I ittear staining in the capillary loops fo r  i(SPG- 
awe is seen in all groups. In contrast, there isa  
marked decnu/se in GIìMdìS staining in tu ice 
teith prolonged albuminuria (group % F), 
there is also some dec recise in (¡HM-US stain­
ing in  m ice teith short duration <f album inuria  
< g ro u p  t, D u  A X 700, B X 700, C X HOO, D
x  r o f ), E x  000, F X 000).
nephropathy4J supports this assumption. An alterna­
tive explanation could be that the reduction of HS as­
sociated negative charges in the GBM facilitates fur­
ther deposition of immune complexes, which is then 
responsible for the ensuing albuminuria, as sug­
gested by the correlation between GBM Ig deposits 
and albuminuria. One should realize, however, that 
these mechanisms are not mutually exclusive and 
could act in concert.
Previously, we have shown that anti-nuclear anti­
bodies complexed to nucleosomal antigens are able 
to bind to HS in wfro19,22 and to the GBM in i//Vo.21,82 
Nucleosomes are built up by histones and DNA and 
are present in nuclei of cells. In these HS or GBM
reactive immune complexes, it is assumed that the 
positively charged histones interact with high affinity 
with the negatively charged HS in the GBM,50 The 
relevance of histones in lupus nephritis with albumin­
uria is further substantiated by the recent detection of 
histones in immune deposits of lupus mice with al­
buminuria, whereas in lupus mice of the same age 
without albuminuria, histones were seldom found.51 
Also, In biopsies of patients with lupus nephritis, his­
tones have been identified in the deposits along the
capillary wall. “ In the study described in this paper, 
we show that nucleosomes and MAbs complexed to 
nucleosomal particles are able to inhibit the binding 
of the anti-HS MAb JM-403 to HS in ELISA whereas
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Figure 7. Agarose gel electrophoresis o f g lya >sa ni i nog (yea i ts ex­
tracted front glomeruli of ihe five groups of mice studied. Lane 1: 
markers. //.V( 20 ng), dermatan sulfate ( AS’, 10 ng), and chondnntin 
st tifale ICS, 10 ng); GAGs iso!ai ed from young 12-iveek-old mice 
{lane 2).- from j6~iveek-old non-alhttmitntric mice (lane 3); from  
age-nuttched non-alhtt min uric controls (lane 4); from mice with 
short dt trat ion o f albuminuria (lane 5); from mice with prolonged, al­
buminuria (lane 6).
purified non-complexed MAb did not. In previous 
studies we showed that histones are also able to in­
hibit this binding.53This suggests thatthe histone part 
within the nucleosome interacts with HS.
In conclusion we found in murine lupus that albu­
minuria is associated with a progressive loss of 
GBM-HS staining. The decrease of HS staining is cor­
related with the increase of GBM-lg deposition. Our
Table 2. IIS Content in Pooled Isolated Glomeruli
Group HS (pg/glomerulus)
* -  M i  « I 1 •
1
2
3
4
5
124
171
152
140
1 1 2
* * r - - 1 (• u  >.'« .
............................................ UuiïtC!0»t|>»WMW>
c0
±:
lec
1
Vp0s
0.7 1.5 3 6 1 2 25 50 1 0 0
concentration (//g/ml)
Figure 8. Inhibition a fb ind ing  o f  the anti-HS M A h ß W t f  to HS a n d  
o f  a n  antUHSIKr MAh to HSPG in BUSA by nucleosomes, p u r i f ia i  
non-complexed anti-n  tic ¡cosante MAhs, a n d  anti-nucleosome MAbs 
complexed b  nucleosoniaiparticles. B ind ing  ofJM~4(),\ was inh ib ited  
dose-dependently by nucleosomes ( H- ) a n d  MAbs complexed fo nu
) hut not by purified  noiK om hlcxvii MAbs < I I >.
In contrast neither nucleosomes nor im m u n e  complexes could inhibit 
the binding ( f a n  anti-HSPG MAb to 1/SPG iO),
in vitro studies suggest that HS may be masked by 
histone-containing immune deposits.
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